2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY EUR J MED CHEM LetPub评分 8.0
61人评分
我要评分
声誉 8.8 影响力 7.2 速度 9.1 | |||||||||||||||||||||||||
| 期刊ISSN | 0223-5234 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||
| E-ISSN | 1768-3254 | |||||||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 注册或登录后，查看影响因子和历年趋势图 | |||||||||||||||||||||||||
| 2021-2022自引率 | 9.60%注册或登录后，查看自引率趋势图 | |||||||||||||||||||||||||
| h-index | 135 | |||||||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||||||
| 期刊简介 | The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets. | |||||||||||||||||||||||||
| 期刊官方网站 | http://www.elsevier.com/wps/find/journaldescription.cws_home/505813/description | |||||||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EJMECH | |||||||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY的语言要求，还能让EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY编辑和审稿人得到更好的审稿体验，让稿件最大限度地被EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||||||
| 通讯方式 | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724 | |||||||||||||||||||||||||
| 出版商 | Elsevier Masson SAS | |||||||||||||||||||||||||
| 涉及的研究方向 | 化学-医药化学 | |||||||||||||||||||||||||
| 出版国家或地区 | FRANCE | |||||||||||||||||||||||||
| 出版语言 | Multi-Language | |||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||||||
| 年文章数 | 916注册或登录后，查看年文章数趋势图 | |||||||||||||||||||||||||
| Gold OA文章占比 | 3.36% | |||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 82.64% | |||||||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：1区
| |||||||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 注册或登录后，查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0223-5234%5BISSN%5D | |||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 平均4.3个月 来源Elsevier官网： 平均7.4周 | |||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 来源Elsevier官网： 32% | |||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均3.7周 | |||||||||||||||||||||||||
| 期刊常用信息链接 | ||||||||||||||||||||||||||
|
|
| |
| 注册或登录后，查看自引率趋势图 |
| 注册或登录后，查看中科院SCI期刊分区趋势图 |
| 注册或登录后，查看年文章数趋势图 |
| 中国学者近期发表的论文 | |
| 1. | Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review Author: M. Xu, S.L. Wang, L. Zhu, P.Y. Wu, W.B. Dai, K.P. Rakesh Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, Vol.164, 448-470, DOI:10.1016/j.ejmech.2018.12.073 DOI |
| 2. | Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors Author: Jianjun Yu, Jieyu Liu, Daqiang Li, Lei Xu, Duidui Hong, Shan Chang, Lei Xu, Jia Li, Tao Liu, Yubo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 423-439, DOI:10.1016/j.ejmech.2018.12.072 DOI |
| 3. | Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives Author: Hongjian Wang, Apeng Wang, Jian Gu, Lei Fu, Kai Lv, Chao Ma, Zeyu Tao, Bin Wang, Mingliang Liu, Huiyuan Guo, Yu Lu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.165, 11-17, DOI:10.1016/j.ejmech.2018.12.071 DOI |
| 4. | Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs Author: Yuanyuan Shan, Ru Si, Jin Wang, Qingqing Zhang, Huaxin Zhou, Jie Song, Jie Zhang, Qinhua Chen Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 440-447, DOI:10.1016/j.ejmech.2018.12.067 DOI |
| 5. | Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents Author: Zheng Li, Yueming Chen, Zongtao Zhou, Liming Deng, Yawen Xu, Lijun Hu, Bing Liu, Luyong Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 352-365, DOI:10.1016/j.ejmech.2018.12.069 DOI |
| 6. | Discovery of 2-substituted-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide as potent and selective protein arginine methyltransferases 5 inhibitors: Design, synthesis and biological evaluation Author: Jingwei Shao, Kongkai Zhu, Daohai Du, Yuanyuan Zhang, Hongrui Tao, Zhifeng Chen, Hualiang Jiang, Kaixian Chen, Cheng Luo, Wenhu Duan Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 317-333, DOI:10.1016/j.ejmech.2018.12.065 DOI |
| 7. | Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles Author: Xiao-Wu Dong, Jian-Kang Zhang, Lei Xu, Jin-Xin Che, Gang Cheng, Xiao-Bei Hu, Li Sheng, An-Hui Gao, Jia Li, Tao Liu, Yong-Zhou Hu, Yu-Bo Zhou Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 602-614, DOI:10.1016/j.ejmech.2018.12.064 DOI |
| 8. | Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivatives as dual inhibitors of BTK and PI3Kδ Author: Linyi Liu, Xinyu Li, Yu Cheng, Lianjian Wang, Huizhu Yang, Jiurong Li, Siying He, shuangjie Wu, Qianqian Yin, Hua Xiang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 304-316, DOI:10.1016/j.ejmech.2018.12.055 DOI |
| 9. | Triptolide-targeted delivery methods Author: Hongtao Xu, Bo Liu Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 342-351, DOI:10.1016/j.ejmech.2018.12.058 DOI |
| 10. | ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway Author: Faiz-Ur Rahman, Amjad Ali, Hong-Quan Duong, Inam Ullah Khan, Muhammad Zeeshan Bhatti, Zhan-Ting Li, Hui Wang, Dan-Wei Zhang Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, Vol.164, 546-561, DOI:10.1016/j.ejmech.2018.12.052 DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共42条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
